Clinical Trial Update: Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial registration to optimize graft-versus-host disease prophylaxis after allogeneic hematopoietic cell transplantation. The study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematological Malignancies

Snippet

Sponsor: University of Nebraska | Conditions: Hematological Malignancies, Graft-versus-Host Disease (GVHD) | Phase 2 | Status: RECRUITING